🔎 Trials Near Me

Gara Jalqabaatti › Myeloma Baay’ee › Kansas › Kansas City

Qorannoo klinikaalii Myeloma Baay’ee Kansas City, KS keessatti

Qorannoo 4 Myeloma Baay’ee f Kansas City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
  • University of Kansas Cancer Center, Kansas City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06465316

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Kansas City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07391657

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 3
  • University of Kansas Cancer Center, Kansas City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07258511

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Namoota walitti qabaa jiraSadarkaa 3
  • American Oncology Partners, P.A. Dba MidAmerica Cancer Care, Kansas City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT06152575

Qorannoo Myeloma Baay’ee magaalota biroo keessatti

Qorannoo biroo Kansas City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.